Dual innovation strategy to create a competitive advantage for Bloomage Biotech / Zhang Zhihong, Zhang Hao, Song Yi.

9781071920909 :

London : SAGE Publications: SAGE Business Cases Originals, 2024.

1 online resource : illustrations.

Access is available to the Yale community.

Description based on XML content.

Access restricted by licensing agreement.

Through China's first microbial fermentation method, Bloomage Biotech uses enzyme digestion to achieve the mass production of hyaluronic acid of different molecular weights, and has become a leading enterprise in the global supply of hyaluronic acid raw materials. As it continues to develop hyaluronic acid end products and explore end consumer markets, it has transformed from a hyaluronic acid raw material supplier to a company with a full industrial chain layout consisting of hyaluronic acid raw materials, medical and aesthetic products, functional skin care products, and functional food products, and was listed on the China A-share market in 2019. This case aims to help students determine disruptive innovation and incremental innovation, and analyze how companies choose strategies and maintain their competitive advantage. Finally, students will explore how companies should choose their future strategy.

Sage Business Cases 2024 Annual Collection.

Books / Online

English

September 17, 2024